Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy

Published:2006-02 Issue:2 Volume:33 Page:271-279
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Dahle Jostein,Borrebæk Jørgen,Melhus Katrine B.,Bruland Øyvind S.,Salberg Gro,Olsen Dag Rune,Larsen Roy H.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference29 articles.

1. What is new in lymphoma?;Cheson;CA Cancer J Clin,2004

2. Treatment of non-Hodgkin's lymphoma;Armitage;N Engl J Med,1993

3. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol,1998

4. 131I-Tositumomab therapy as initial treatment for follicular lymphoma;Kaminski;N Engl J Med,2005

5. Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience;Kaminski;Blood,2000

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actinium-225 targeted alpha particle therapy for prostate cancer;Theranostics;2024

2. DTPA(DOTA)-Nimotuzumab Radiolabeling with Generator-produced Thorium for Radioimmunotherapy of EGFR-overexpressing Carcinomas;Current Radiopharmaceuticals;2023-09

3. Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals;Inorganic Chemistry;2023-08-17

4. Evaluation of Candidate Theranostics for²²⁷Th/⁸⁹Zr Paired Radioimmunotherapy of Lymphoma;Journal of Nuclear Medicine;2023-05-04

5. Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update;Seminars in Nuclear Medicine;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3